Science
Cornell Research Team To Develop COVID-19 Nose Spray Treatment
|
Researchers from Cornell University have discovered a new molecule called N-0385 that could be used to develop the first COVID-19 nose spray, a medication taken intranasally.
Science
Cornell Professors Explain Possible Risks and Benefits of COVID-19 Antiviral Treatment
|
The first-ever COVID antiviral pill developed by Merck could be available before the end of the year. The drug, molnupiravir, has been shown to reduce the risk of hospitalization and death from COVID-19 by 50 percent, and on Oct. 11, Merck requested the Food and Drug Administration for an emergency authorization of the pill.
Science
Preparing for a New Normal, Researchers Study Molecular Basis for COVID Drug Similar to Tamiflu
|
Prof. Christopher Alabi, chemical and biomolecular engineering, released a study for peer review on a mechanism that successfully blocked the transmission of SARS-CoV-2 in ferrets. Alabi’s co-authors on the study are now applying for a patent that would make use of this discovery in a drug.